Stage Cell Therapeutics
Enterprise value
$22m
Company register number
HRB 242321 (München)
| Date | Investors | Amount | Round |
|---|---|---|---|
$22.0m Valuation: $22.0m | Acquisition | ||
| Total Funding | 000k | ||
| EUR | 2017 | 2020 | 2021 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| % growth | - | - | (46 %) |
| EBITDA | 0000 | 0000 | 0000 |
| % EBITDA margin | (1211 %) | (473 %) | (1126 %) |
| Profit | 0000 | 0000 | 0000 |
| % profit margin | (1282 %) | (493 %) | (1169 %) |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads